TheEdgeResearch
Home / Stocks / HNGE

Hinge Health, Inc. (HNGE)

NYSE Healthcare Medical - Healthcare Information Services
$87.36 ▼ -1.85%
Market Cap
$6.76B
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Beta
1.28
52-Wk Range
30.08-93.13
CEO
Daniel A. Perez
Country
US
Currency
USD

Hinge Health, Inc. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in San Francisco, CA, US. The stock last traded at $87.36, down 1.85% on the session, giving a market capitalisation of $6.76B. On trailing twelve-month figures it carries a trailing P/E of 64.87, a net margin of 15.1%. Its beta of 1.28 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
64.87
Price / Sales
9.39
Price / Book
19.99
EV / EBITDA
62.97
Gross margin
84.5%
Operating margin
13.0%
Net margin
15.1%
Return on equity
Debt / equity
0.02
Current ratio
1.34
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
New York Stock Exchange
Employees
1,437
IPO date
2025-05-22
Headquarters
San Francisco, CA, US
About Hinge Health, Inc.

Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.

Comparable companies

Hinge Health, Inc. is most often compared with the following Healthcare names:

AKROCRNXDYNIMVTINDVLNTHOSCRPRAXVKTXWGS
More research on HNGE
HNGE technical analysis HNGE TheEdge Score Compare against peers
Open full interactive analysis & DCF →